Urethral cancer diagnostic study of choice

Jump to navigation Jump to search

Urethral cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Urethral cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Urethral cancer diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Urethral cancer diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Urethral cancer diagnostic study of choice

CDC on Urethral cancer diagnostic study of choice

Urethral cancer diagnostic study of choice in the news

Blogs on Urethral cancer diagnostic study of choice

Directions to Hospitals Treating Urethral cancer

Risk calculators and risk factors for Urethral cancer diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]

Overview

There is no single diagnostic study of choice for diagnosing urethral cancer. Cystourethroscopy is useful to evaluate the extent of the disease. Definitive diagnosis is made with transurethral biopsies.

Diagnostic Study of Choice

Study of choice

There is no single diagnostic study of choice for the diagnosis of urethral cancer;

References

  1. Guercio S, Terrone C, Scarpa RM (March 2003). "[Clinical surveillance after surgery for prostate cancer]". Recenti Prog Med (in Italian). 94 (3): 110–3. PMID 12677777.

Template:WH Template:WS